rs760077990
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000296695.10(SPINK1):c.203A>G(p.Gln68Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000948 in 1,613,922 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q68L) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000296695.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPINK1 | NM_001379610.1 | c.203A>G | p.Gln68Arg | missense_variant | 4/4 | ENST00000296695.10 | NP_001366539.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPINK1 | ENST00000296695.10 | c.203A>G | p.Gln68Arg | missense_variant | 4/4 | 1 | NM_001379610.1 | ENSP00000296695 | P1 | |
SPINK1 | ENST00000505722.1 | n.118A>G | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000108 AC: 27AN: 250422Hom.: 0 AF XY: 0.0000960 AC XY: 13AN XY: 135396
GnomAD4 exome AF: 0.000101 AC: 147AN: 1461724Hom.: 0 Cov.: 31 AF XY: 0.0000963 AC XY: 70AN XY: 727166
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74348
ClinVar
Submissions by phenotype
Hereditary pancreatitis Uncertain:3Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 68 of the SPINK1 protein (p.Gln68Arg). This variant is present in population databases (rs760077990, gnomAD 0.08%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with pancreatitis (PMID: 17003641). ClinVar contains an entry for this variant (Variation ID: 410700). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on SPINK1 function (PMID: 22343981, 28994706, 33515547). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | Apr 04, 2021 | - - |
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 13, 2024 | Variant summary: SPINK1 c.203A>G (p.Gln68Arg) results in a conservative amino acid change located in the Kazal domain (IPR002350) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00011 in 250422 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in SPINK1 causing Chronic Pancreatitis (0.00011 vs 0.00025), allowing no conclusion about variant significance. c.203A>G has been reported in the literature in individuals affected with Chronic Pancreatitis (examples: Keiles_2006, Szabo_2021) however one of these cases was reported with another pathogenic PRSS1 variant (N29I; Keiles_2006). These report(s) do not provide unequivocal conclusions about association of the variant with Chronic Pancreatitis. Multiple studies have reported conflicting experimental evidence related to this variant (examples: Boulling_2012, Wu_2017, Szabo_2021). The following publications have been ascertained in the context of this evaluation (PMID: 22343981, 17003641, 33515547, 28994706). ClinVar contains an entry for this variant (Variation ID: 410700). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jun 09, 2019 | The SPINK1 c.203A>G; p.Gln68Arg variant (rs760077990) is reported in the literature in a single individual affected with pancreatitis, who also carried a pathogenic PRSS1 variant (Keiles 2006). This variant is reported as uncertain significance by multiple laboratories in ClinVar (Variation ID: 410700), and is found in the general population with an allele frequency of 0.010% (29/281824 alleles) in the Genome Aggregation Database. The glutamine at codon 68 is moderately conserved, and computational analyses (SIFT: tolerated, PolyPhen-2: possibly damaging) predict conflicting effects of this variant on protein structure/function. In vitro functional analyses show increased protein expression (Boulling 2012) but slightly decreased mRNA expression (Wu 2017). Due to limited information, the clinical significance of the p.Gln68Arg variant is uncertain at this time. References: Boulling A et al. Functional analysis of eight missense mutations in the SPINK1 gene. Pancreas. 2012 Mar;41(2):329-30. Keiles S and Kammesheidt A. Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis. Pancreas. 2006 Oct;33(3):221-7. Wu H et al. Analysis of the Impact of Known SPINK1 Missense Variants on Pre-mRNA Splicing and/or mRNA Stability in a Full-Length Gene Assay. Genes (Basel). 2017 Oct 10;8(10). pii: E263. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Dec 16, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at